China SXT Pharmaceuticals, Inc.
SXTC
$3.30
$0.000.00%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 255.70K | 255.70K | 313.30K | 313.30K | 455.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 255.70K | 255.70K | 313.30K | 313.30K | 455.70K |
| Cost of Revenue | 182.30K | 182.30K | 262.40K | 262.40K | 339.40K |
| Gross Profit | 73.50K | 73.50K | 50.90K | 50.90K | 116.30K |
| SG&A Expenses | 465.50K | 465.50K | 3.22M | 3.22M | 1.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 647.70K | 647.70K | 3.48M | 3.48M | 1.48M |
| Operating Income | -392.00K | -392.00K | -3.17M | -3.17M | -1.02M |
| Income Before Tax | 81.90K | 81.90K | -3.18M | -3.18M | -1.25M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 81.90K | 81.90K | -3.18M | -3.18M | -1.25M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 81.90K | 81.90K | -3.18M | -3.18M | -1.25M |
| EBIT | -392.00K | -392.00K | -3.17M | -3.17M | -1.02M |
| EBITDA | -371.20K | -371.20K | -3.15M | -3.15M | -1.01M |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |